Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

215 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan).
Brenner BM, Cooper ME, de Zeeuw D, Grunfeld JP, Keane WF, Kurokawa K, McGill JB, Mitch WE, Parving HH, Remuzzi G, Ribeiro AB, Schluchter MD, Snavely D, Zhang Z, Simpson R, Ramjit D, Shahinfar S; RENAAL Study Investigators. Brenner BM, et al. Among authors: mcgill jb. J Renin Angiotensin Aldosterone Syst. 2000 Dec;1(4):328-35. doi: 10.3317/jraas.2000.062. J Renin Angiotensin Aldosterone Syst. 2000. PMID: 11967819 Clinical Trial.
The effect of ruboxistaurin on nephropathy in type 2 diabetes.
Tuttle KR, Bakris GL, Toto RD, McGill JB, Hu K, Anderson PW. Tuttle KR, et al. Among authors: mcgill jb. Diabetes Care. 2005 Nov;28(11):2686-90. doi: 10.2337/diacare.28.11.2686. Diabetes Care. 2005. PMID: 16249540 Clinical Trial.
Body weight changes with beta-blocker use: results from GEMINI.
Messerli FH, Bell DS, Fonseca V, Katholi RE, McGill JB, Phillips RA, Raskin P, Wright JT Jr, Bangalore S, Holdbrook FK, Lukas MA, Anderson KM, Bakris GL; GEMINI Investigators. Messerli FH, et al. Among authors: mcgill jb. Am J Med. 2007 Jul;120(7):610-5. doi: 10.1016/j.amjmed.2006.10.017. Am J Med. 2007. PMID: 17602935 Clinical Trial.
215 results